These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 16208618
1. Multimodality treatment of neuroendocrine tumors of the thymus. Dosios T, Nikou GC, Toubanakis C, Filippides T, Papachristou D. Thorac Cardiovasc Surg; 2005 Oct; 53(5):305-9. PubMed ID: 16208618 [Abstract] [Full Text] [Related]
2. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Goto K, Kodama T, Matsuno Y, Yokose T, Asamura H, Kamiya N, Shimosato Y. Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168 [Abstract] [Full Text] [Related]
3. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature. Filosso PL, Actis Dato GM, Ruffini E, Bretti S, Ozzello F, Mancuso M. J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1215-9. PubMed ID: 15052231 [No Abstract] [Full Text] [Related]
8. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Moran CA, Suster S. Am J Clin Pathol; 2000 Jul; 114(1):100-10. PubMed ID: 10884805 [Abstract] [Full Text] [Related]
10. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment]. Langfort R, Rudziński P, Burakowska B. Pneumonol Alergol Pol; 2010 Jul; 78(1):33-46. PubMed ID: 20162517 [Abstract] [Full Text] [Related]
11. Two cases of atypical carcinoid of the thymus. Fujiwara K, Segawa Y, Takigawa N, Kishino D, Ida M, Eguchi K, Nakata M, Saeki H, Mandai K. Intern Med; 2000 Oct; 39(10):834-8. PubMed ID: 11030210 [Abstract] [Full Text] [Related]
12. [Neuroendocrine tumors of the larynx]. Waśniewska E, Wierzbicka M, Majewski P, Szyfter W. Otolaryngol Pol; 2004 Oct; 58(6):1097-101. PubMed ID: 15732829 [Abstract] [Full Text] [Related]
13. Thymic neuroendocrine tumour (carcinoid): clinicopathological features of four patients with different presentation. Dutta R, Kumar A, Julka PK, Mathur SR, Kaushal S, Kumar R, Jindal T, Suri V. Interact Cardiovasc Thorac Surg; 2010 Dec; 11(6):732-6. PubMed ID: 20851876 [Abstract] [Full Text] [Related]
15. Lung and Thymic Carcinoids. Hann CL, Forde PM. Endocrinol Metab Clin North Am; 2018 Sep; 47(3):699-709. PubMed ID: 30098725 [Abstract] [Full Text] [Related]
16. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver. Chung MH, Pisegna J, Spirt M, Giuliano AE, Ye W, Ramming KP, Bilchik AJ. Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323 [Abstract] [Full Text] [Related]
17. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Tiffet O, Nicholson AG, Ladas G, Sheppard MN, Goldstraw P. Chest; 2003 Jul; 124(1):141-6. PubMed ID: 12853516 [Abstract] [Full Text] [Related]
19. Primary neuroendocrine carcinoma (thymic carcinoid) of the thymus with prominent oncocytic features: a clinicopathologic study of 22 cases. Moran CA, Suster S. Mod Pathol; 2000 May; 13(5):489-94. PubMed ID: 10824919 [Abstract] [Full Text] [Related]